Johnson & Johnson CFO on Q2 earnings beat

6:50 AM ET Tue, 17 July 2018

Joseph Wolk, Johnson & Johnson CFO, breaks down the company's quarterly numbers which beat on the top and bottom line, helped by improved cancer drug sales.